Gracell Biotechnologies (NASDAQ:GRCL) said on Tuesday that its shareholders have approved a proposed merger between the China-based biopharmaceutical company and AstraZeneca (AZN). The extraordinary ...
Source LinkGracell Biotechnologies (NASDAQ:GRCL) said on Tuesday that its shareholders have approved a proposed merger between the China-based biopharmaceutical company and AstraZeneca (AZN). The extraordinary ...
Source Link
Comments